Cactus grandiflorus 30C (Paramesh Banerji Life Sciences LLC)


Welcome to the PulseAid listing for the Cactus grandiflorus 30C drug offered from Paramesh Banerji Life Sciences LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Paramesh Banerji Life Sciences LLC
NON-PROPRIETARY NAME: Cactus grandiflorus
SUBSTANCE NAME: SELENICEREUS GRANDIFLORUS STEM
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-06-15
END MARKETING DATE: 0000-00-00


Cactus grandiflorus 30C HUMAN OTC DRUG Details:

Item DescriptionCactus grandiflorus 30C from Paramesh Banerji Life Sciences LLC
LABELER NAME: Paramesh Banerji Life Sciences LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 30([hp_C]/1)
START MARKETING DATE: 2015-06-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69152-1099_188c9764-ee95-5242-e054-00144ff8d46c
PRODUCT NDC: 69152-1099
APPLICATION NUMBER:

Other SELENICEREUS GRANDIFLORUS STEM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
HOMEOLAB USA INC.CACTUS GRANDIFLORUS
Natural Health SupplyNHS Spasms Weakness
Paramesh Banerji Life Sciences LLCCactus grandiflorus 200C
Rxhomeo Private Limited d.b.a. Rxhomeo, IncCACTUS GRANDIFLORUS
Seroyal USACACTUS GRANDIFLORUS
Washington Homeopathic ProductsCactus grandiflorus